Literature DB >> 3688958

[Radioimmunoscintigraphy in ovarian cancer: theoretical principles and clinical experiences].

E Gitsch, N Pateisky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3688958     DOI: 10.1007/bf01783164

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


× No keyword cloud information.
  3 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Intraoperative lymph scintigraphy during radical surgery for cervical cancer.

Authors:  E Gitsch; K Philipp; N Pateisky
Journal:  J Nucl Med       Date:  1984-04       Impact factor: 10.057

3.  Radioimmunodetection in patients with suspected ovarian cancer.

Authors:  N Pateisky; K Philipp; W D Skodler; K Czerwenka; G Hamilton; J Burchell
Journal:  J Nucl Med       Date:  1985-12       Impact factor: 10.057

  3 in total
  5 in total

1.  Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer.

Authors:  J Brökelmann; A Bockisch; J Vogel; J Reinsberg; P Oehr; H J Biersack; D Krebs
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Immunohistochemical identification of CA125 and the F(ab')2 fragments of the murine monoclonal antibody OC125 in ovarian cancer tissue.

Authors:  G Ronay; W Jäger; K Weiss; H Feistel; F Wolf; A H Tulusan; N Lang
Journal:  Br J Cancer Suppl       Date:  1990-07

Review 3.  The role of nuclear medicine in oncology.

Authors:  H J Biersack; B Briele; A L Hotze; P Oehr; L Qian; M A Mekkawy; W J Shih
Journal:  Ann Nucl Med       Date:  1992-08       Impact factor: 2.668

Review 4.  Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer.

Authors:  G Fleckenstein; R Osmers; J Puchta
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

5.  Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences.

Authors:  C Alexander; C E Villena-Heinsen; L Trampert; S Lung-Kurt; E Oberhausen; C M Kirsch; W Schmidt
Journal:  Eur J Nucl Med       Date:  1995-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.